Caribou Biosciences (CRBU) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Caribou Biosciences (CRBU) over the last 6 years, with Q3 2025 value amounting to -$147.3 million.
- Caribou Biosciences' Enterprise Value rose 3546.31% to -$147.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$147.3 million, marking a year-over-year increase of 3546.31%. This contributed to the annual value of -$209.5 million for FY2024, which is 3627.74% up from last year.
- As of Q3 2025, Caribou Biosciences' Enterprise Value stood at -$147.3 million, which was up 3546.31% from -$183.9 million recorded in Q2 2025.
- In the past 5 years, Caribou Biosciences' Enterprise Value ranged from a high of -$129.5 million in Q2 2021 and a low of -$435.3 million during Q3 2021
- Its 5-year average for Enterprise Value is -$263.7 million, with a median of -$259.2 million in 2023.
- As far as peak fluctuations go, Caribou Biosciences' Enterprise Value plummeted by 225587.04% in 2021, and later soared by 3627.74% in 2024.
- Caribou Biosciences' Enterprise Value (Quarter) stood at -$375.8 million in 2021, then surged by 34.1% to -$247.7 million in 2022, then tumbled by 32.77% to -$328.8 million in 2023, then skyrocketed by 36.28% to -$209.5 million in 2024, then increased by 29.72% to -$147.3 million in 2025.
- Its Enterprise Value stands at -$147.3 million for Q3 2025, versus -$183.9 million for Q2 2025 and -$208.5 million for Q1 2025.